Silent brain metastasis in the initial staging of lung cancer. Evaluation by computed tomography and magnetic resonance imaging;Metástasis encefálicas silentes en la estadificación inicial del cáncer de pulmón. Evaluación mediante tomografía computarizada y resonancia magnética

Archivos de Bronconeumologia

Volumn 43, Issue 7, 2007, Pages 386-391

  Sánchez De Cos Escuín, Julio ^a,c   Masjoans Menna, Diego ^b   Sojo González, M Agustín ^a   Zamorano Quirantes, José ^a   Disdier Vicente, Carlos ^a   Pérez Calvo, María Cristina ^a  

^a HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^b Unidad de Resonancia Magnética   (Spain)

^c NONE   (Spain)

Author keywords

Computed tomography; Lung cancer; Magnetic resonance imaging; Silent brain metastasis

Indexed keywords

GADOLINIUM PENTETATE; IOPROMIDE; LAROGRAF; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ARTICLE; BRAIN METASTASIS; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HISTOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MONITORING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; SEX;

EID: 34548389291     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S1579-2129(07)60090-1     Document Type: Article

References (22)

1. th Annual Meeting of American Society of Clinical Oncology. Orlando: American Society of Clinical Oncology; 2002. p. 383-91.
2. Schouten LJ, Rutten J, Huveneers HAM Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer. 2002;94:2698-705.
3. Silvestri GA, Littenberg B, Colice GL. The clinical evaluation for detecting metastatic lung cancer. A metaanalysis. Am J Respir Crit Care Med. 1995;152:225-30.
4. The American Thoracic Society and The European Respiratory Society. Pretreatment evaluation of non-small cell lung cancer. Am J Respir Crit Care Med. 1997;156:320-32.
5. Silvestri GA, Tanoue LT, Margolis ML, Barker J, Detterbeck F. The noninvasive staging of non-small cell lung cancer. Chest. 2003;123:147S-56S.
6. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer. A review of the current evidence. Chest. 2003;123:137S-46S.
7. Pfister DG, Johnson DH, Azzoli ChG, Sause W, Smith TJ, Baker SH Jr, et al. American Society of Clinical Oncology. Treatment of unresectable non-small cell lung cancer guideline: update 2003. J Clin Oncol. 2004;22:330-53.
8. Sze G, Shin J, Krol G, Johnson C, Liu D, Deck MDF. Intraparenchymal brain metastases: MR Imaging versus contrast-enhanced CT. Radiology. 1988;168:187-94.
9. Yokoi K, Kamiya N, Matsuguma H, Machida S, Hirose T, Kiyoshi M, et al. Detection of brain metastasis in potentially operable non-small cell lung cancer. A comparison of CT and MRI. Chest. 1999;115:714-9.
10. Earnest F, Ryn JH, Miller GM, Luetmer PH, Foestrom LA, Burnett OL, et al. Suspected non-small cell lung cancer: Incidence of occult brain and skeletal metastases and effectiveness of imaging for detection. Pilot study. Radiology. 1999;211:137-45.
11. Hochstenbag MMH, Twijnstra A, Hofman P, Wouters EFM, Ten Velde GPM. MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment? Lung Cancer. 2003;42:189-93.
12. Mountain CF. Revisions in the International System for staging lung cancer. Chest. 1997;111:1710-7.
13. Salbeck R, Grau HC, Artmann H. Cerebral tumor-staging in patients with bronchial carcinoma by computed tomography. Cancer. 1990;66:2007-11.
14. Ferrigno D, Buccheri G. Cranial computed tomography as a part of the initial staging procedures for patients with non small cell lung cancer. Chest. 1994;106:1025-9.
15. Kormas P, Bradshaw JR, Jeyasingham K. Preoperative computed tomography of the brain in non-small cell bronchogenic carcinoma. Thorax. 1992;47:106-8.
16. Salvatierra A, Baamonde C, Llamas JM, Cruz F, López-Pujol J. Extrathoracic staging of bronchogenic carcinoma. Chest. 1990;97: 1052-8.
17. Schellinger PD, Meinck HM, Thron A. Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J Neurooncol. 1999;44:275-81.
18. th Annual Meeting of American Society of Clinical Oncology. Orlando: American Society of Clinical Oncology; 2002. p. 375-82.
19. Vogelbaum MA, Suh JH. Resectable brain metastases. J Clin Oncol. 2006;24:1289-94.
20. Sánchez de Cos J, Miravet L, Núñez A, Hernández J, Abal J, Montero C, et al. Lung cancer in Spain. Last epidemiological trends concerning age, gender, smoking prevalence and histological types (abstract only, 11th World Conference on Lung Cancer, July 2005. Barcelona, Spain). Lung Cancer. 2005;49 Suppl: 197.
21. Bonnette P, Puyo P, Gabriel C, Giudicelli R, Regnard JF, Riquet M, et al. Surgical management of non-small cell lung cancer with synchronous brain metastases. Chest. 2001;119: 1469-75.
22. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363:1665-72.